More Business Wire
View Older Stories View Newer Stories-
Phillips & Jordan, Inc. Rebrands as Phillips Heavy, Inc.; Phillips Infrastructure Holdings Evolves into Phillips Infrastructure Corp.
-
Arcus Biosciences Announces New Employment Inducement Grants
-
Victory Capital Reports September 2025 Total Client Assets
-
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
-
BP Prudhoe Bay Royalty Trust Announces Final Distribution to Unitholders
-
CommScope to Release Third Quarter 2025 Financial Results on October 30
-
Seadrill Announces Third Quarter 2025 Earnings Release and Conference Call
-
Granite Announces Bridge Replacements Along Historic Route 66
-
Q2 Holdings, Inc. to Attend Upcoming Conference During Fourth Quarter 2025
-
Ryder Declares Quarterly Cash Dividend
-
Pfizer Declares Fourth-Quarter 2025 Dividend
-
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs
-
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
-
Corbin Advisors Releases Q3’25 Inside The Buy-Side® Earnings Primer®
-
From Patient to Astronaut: St. Jude Unveils Hayley Arceneaux’s Spacesuit
-
Helmerich & Payne, Inc. Schedules Fiscal Fourth Quarter 2025 and Year End Conference Call and Webcast
-
AIG to Report Third Quarter 2025 Financial Results on November 4, 2025, and Host Conference Call on November 5, 2025
-
Levi Strauss & Co. Reports Third-Quarter 2025 Financial Results
-
Hamilton to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Paramount Announces Release Date for Third Quarter 2025 Results
-
BeFra Announces Third Quarter 2025 Earnings Release Date, Conference Call and Webcast
-
Genworth Financial Schedules Earnings Conference Call for November 6
-
NYSE Group Consolidated Short Interest Report
-
Zoetis Declares Fourth Quarter 2025 Dividend
-
Eaton’s Changzhou Smart Factory Selected to Join the World Economic Forum’s Global Lighthouse Network
-
Walmart Highlights U.S. Manufacturing and Small Business Growth at 2025 Open Call
-
Camden Property Trust Announces Third Quarter 2025 Earnings Release and Conference Call Dates
-
Nick Chan Appointed Head of M&A for Equitable Holdings
-
Cloudflare Announces Date of Third Quarter 2025 Financial Results
-
Fluor Completes Successful Sale of NuScale Class A Shares
-
Texas Pacific Land Corporation Sets Dates for Third Quarter 2025 Earnings Release and Conference Call
-
Amalgamated Financial Corp. Announces Third Quarter 2025 Earnings Conference Call
-
Darling Ingredients Inc. to Release Third Quarter 2025 Financial Results
-
DHI Group, Inc. to Participate in the LD Micro Main Event Investor Conference on October 20, 2025
-
Registration Continues for the Second Edition of “Miyahthon” to Advance Innovation in Water Sustainability
-
Flexsteel Industries, Inc. Announces Change to Board of Directors
-
Snap Inc. Announces Date of Third Quarter 2025 Results Conference Call
-
Webster Financial Corporation Announces Q3 2025 Earnings Release and Conference Call
-
Reddit to Announce Third Quarter 2025 Results on Thursday, October 30, 2025
-
RB Global to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
-
KB Home Declares Fourth Quarter 2025 Dividend
-
USANA Health Sciences Provides Preliminary Third Quarter Results
-
IMAX Corporation to Announce Third-Quarter 2025 Financial Results and Host Conference Call
-
Joby Aviation Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
NOG Schedules Third Quarter Earnings Release and Conference Call
-
SRP and ESS Announce New 50 MWh Long Duration Energy Storage Pilot Project
-
Western Union to Release Third Quarter 2025 Results on October 23, 2025
-
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
-
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for
-
Jack in the Box Announces Fourth Quarter and Full-Year 2025 Earnings Webcast
